A former executive from Hologic has been selected to spearhead the upcoming growth and commercial strategies for ImpediMed, a major player in medical technology. The company, based in CARLSBAD, Calif., announced this development on April 7, 2026, via a press release on PRNewswire. ImpediMed specializes in creating and bringing to market technologies focused on actively monitoring and controlling fluid levels and body status. This change in leadership is aimed at propelling ImpediMed into its next phase of expansion and operational success.